Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curing Chronic Wounds With Fibrin
2017-000863-34Phase 2Active
- Start
- Apr 2017
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Fibrinogen human and thrombin in Chronic wound, leg ulcer and foot ulcer. Primary endpoints: Primary wound healing endpoint at 12 weeks, Change in wound volume at week 12 and 3 more. Started Apr 2017; status: active.
02
Drugs
Fibrinogen humanthrombin
03
Conditions
Chronic woundleg ulcerfoot ulcer
Beyond the preview
Go deeper on 2017-000863-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000863-34.